Skin melanoma, a malignancy originating from melanocytes, presents a formidable clinical challenge due to its aggressive behavior and propensity for metastasis.Recent years have witnessed significant strides in elucidating the molecular intricacies of melanoma pathogenesis, fostering the identification of novel diagnostic and therapeutic avenues.This review encapsulates the latest developments in the realm of skin melanoma, accentuating breakthroughs in early detection modalities such as dermoscopy, reflectance confocal microscopy, and molecular biomarkers.Additionally, it delves into the paradigm shift toward personalized medicine, with targeted therapies and immunotherapies emerging as cornerstones in melanoma management.Moreover, the integration of cutting-edge technologies, including artificial intelligence, holds promise in refining diagnostic accuracy and treatment efficacy.By synthesizing these recent advancements, this review underscores the imperative of ongoing research endeavors in combating melanoma and enhancing patient outcomes.
No takes yet. Share an insight, caveat, or question.
Vishnoi et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: